Medyria raises $3.9M (Switzerland, Jul 2026)
$3.9M
CHF 3.5 millionGenerated social card
Headline
Medyria raises CHF 3.5 million - Startupticker.ch
About
Medyria is a Swiss medical technology pioneer specializing in invasive coronary diagnostics. The company develops blood-flow-velocity sensors and catheter technologies, with its lead product, PyCath, designed to measure blood flow velocity during interventional cardiology procedures.
Article summary
Medyria raises CHF 3.5 million Startupticker.ch
Founder
Mauro M. Sette
CEO
Investors
Related rounds
| Jun 18, 2026 | reltix | $3.2M | Pre-seed | Switzerland |
| Jun 16, 2026 | ZAAN | $5.0M | — | Switzerland |
| Jun 05, 2026 | GR3N | $16.5M | Series B | Switzerland |
| May 28, 2026 | Stellar Alpina | $4.0M | — | Switzerland |